De meest voorkomende klachten zijn maag- en darmklachten zoals misselijkheid, diarree, overgeven en constipatie
10 This finding suggests that while the increase in prescriptions is partially attributable to disease burden, other influences are likely at play
However, it is yet to be approved for any indications beyond glycemic control
AOD-9604 produces modest weight loss (2-3 kg over 12 weeks in trials) through peripheral fat tissue activation without any appetite effects
These brands are approved for different uses, like cardiovascular risk reduction, obstructive sleep apnea or for kidney or liver conditions
May your peptides stay pure, your protocols stay evidence-based, and your decisions stay informed.